ERβ |
Estrogen receptor β |
ERα |
Estrogen receptor α |
ERE |
Estrogen response element |
E2 |
17β-Estradiol |
DC |
Dendritic cell |
Treg |
Regulatory T cell |
SERM |
Selective estrogen receptor modulator |
SERD |
Selective estrogen receptor degrader |
IHC |
Immunohistochemistry |
IF |
Immunofluorescence |
Th2 |
T helper 2 |
Th1 |
T helper 1 |
IL-4 |
Interleukin-4 |
IFNγ |
Interferon Gamma |
IL-6 |
Interleukin-6 |
TNFα |
Tumor necrosis factor alpha |
TME |
Tumor microenvironment |
EGF |
Epidermal growth factor |
IGF |
Insulin growth factor |
FGF |
Fibroblast growth factor |
OS |
Overall survival |
NSCLC |
Non-small cell lung cancer |
CAF |
Cancer associated fibroblast |
TAM |
Tumor associated macrophage |
MDSC |
Myeloid derived suppressor cell |
MPP |
Methylpiperidino pyrazole |
NK |
Natural killer |
LRH-1 |
Liver receptor homolog-1 |
PCR |
Polymerase chain reaction |
PI3K |
Phosphatidylinositide 3-kinase |
MAPK |
Mitogen-activated protein kinase |
CCL5 |
C–C motif chemokine ligand 5 |
IL-12 |
Interleukin-12 |
VEGF |
Vascular endothelial growth factor |
HGSOC |
High grade serous ovarian cancer |
IL-17A |
Interleukin-17A |
STAT3 |
Signal transducer and activator of transcription 3 |
TIL |
Tumor infiltrating lymphocyte |
AI |
Aromatase inhibitor |
CTL |
Cytotoxic T lymphocyte |
PI-9 |
Proteinase inhibitor-9 |
PD-1 |
Programmed death-1 |
PD-L1 |
PD-1 ligand |
COX-2 |
Cyclooxygenase-2 |
PGE2 |
Prostaglandin E2 |
NSAID |
Nonsteroidal anti-inflammatory drug |
AP-1 |
Activator protein-1 |
CTLA4 |
Cytotoxic T-lymphocyte–associated antigen 4 |